C. Difficile Infection Equipment
-
Manufactured by Finch Therapeutics Group, Inc.based in USA
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most urgent antibiotic resistant threats and the most common cause of healthcare associated ...
-
Manufactured by Pro-Lab Diagnosticsbased in UNITED KINGDOM
The Proflow™ C. difficile GDH test kit is a single use rapid membrane immunoassay for the qualitative detection of Glutamate Dehydrogenase (GDH) in human faecal samples to aid in the diagnosis of Clostridium difficile (C. difficile) infection. ...
-
Manufactured by HiberGene Diagnosticsbased in IRELAND
Diagnosing C. difficile infection early allows patients to be discharged earlier, frees up bed space and reduces costs. Clostridium difficile (C. difficile), the major cause of hospital-acquired diarrhoea, is highly infectious and can spread rapidly in healthcare facilities if not identified and ...
-
Manufactured by Seres Therapeutics, Inc.based in USA
SER-109 is a first-in-class investigational microbiome therapeutic administered orally following antibiotics to reduce recurrence of C. difficile infection (CDI) in patients with recurrent ...
-
Manufactured by Finch Therapeutics Group, Inc.based in USA
CP101, an orally administered, Complete Consortia product candidate in late-stage clinical development for the prevention of recurrent C. difficile infection is also being developed for the treatment of chronic HBV. Chronic HBV infection occurs when the initial immune response fails to clear the virus, and may result in ...
-
Manufactured by Vedanta Biosciences, Incbased in USA
VE303 is an orally administered, rationally-defined bacterial consortium candidate being developed for high-risk Clostridioides difficile (CDI) infection. VE303 consists of 8 types of clonal human commensal bacteria strains selected for their ability to provide colonization resistance to C. difficile and manufactured under cGMP ...
-
Manufactured by Cepheidbased in USA
The epidemic strain of Clostridium difficile (027/NAP1/BI) is known to produce a significantly higher number of C. difficile spores and toxins. The epidemic strain has also been identified as a cause of hospital outbreaks worldwide. Healthcare professionals can now be informed on the epidemic C. difficile ...
-
Manufactured by Cepheidbased in USA
; Rapid identification of infected patient helps infection control efforts; Timely reporting enables clinicians to administer appropriate therapy thereby improving patient management. Cepheid’s Xpert C. difficile test provides on-demand results you can trust and empowers your clinical team to better manage ...
-
Manufactured by Accelerate Diagnostics, Inc.based in USA
Easier for the lab. Earlier for clinicians. Fast MIC results. Direct from positive blood cultures. Now with optional ID, and affordably ...
-
Manufactured by Destiny Pharma plcbased in UNITED KINGDOM
Background to the NTCD-M3 Clostridioides difficile Programme. NTCD-M3 was developed by GI infection physician, Professor Dale Gerding, who is a world-leading specialist in C. difficile, with more than 400 peer-reviewed journal publications, book chapters and review articles in the area. NTCD-M3 has successfully completed Phase 1 ...
-
Manufactured by Lumen Bioscience, Inc.based in USA
Traditionally considered a hospital-acquired infection, C. difficile is increasingly arising in the broader community. For this reason, the shelf-stable, orally delivered format of Lumen’s product is an important addition to the tool kit for treating and preventing this disease. Long-term consequences can include chronic diarrhea, ...
-
by CHROMagarbased in FRANCE
24 h of anaerobic incubation at 35-37 °C. CHROMagar™ C.difficile is not intended to diagnose an infection nor to guide nor monitor treatment for infections. A lack of growth or the absence of fluorescent colonies on CHROMagar™ C.difficile does not preclude the presence of C. difficile. Further ...
-
Manufactured by Omni-Bioticbased in USA
Omni-Biotic AB 10 is a probiotic supplement specifically developed to effectively restore and maintain microbiome diversity in the gut. Restores and maintains bacterial diversity in the gastrointestinal microbiome. Supports gut microbiome balance and function. Reduces antibiotic associated ...
-
Manufactured by Lumos Diagnosticsbased in USA
FebriDx is a rapid, all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. FebriDx® can be used to help triage patients at the point of care to reduce uncertainty and avoid unnecessary antibiotics. Results within 10 minutes increases confidence in whether or not to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you